Skip to main content

Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27

News


Abstract

Antimicrobial resistance (AMR) poses an important global health challenge, including insufficient investment in research and development. This study quantifies the required fair share" contributions from the G7+EU27 countries for an effective set of pull incentives for antibacterial research and development."
Key Data

  • Publication Date
    08 September 2025
  • Primary Author
    Matt McEnany
  • Source
    sciencedirect.com
  • Language
    English
Click below to visit original source: